0 likes | 11 Views
At Healthark Insights, we partnered with a leading global biopharmaceutical company to support the launch of an innovative oncology product in the UAE, KSA, and Kuwait. By conducting a detailed pre-launch Awareness, Trial, and Usage (ATU) study, we provided actionable insights into treatment practices, diagnostic trends, and physician perceptions.
E N D
CASE STUDY ATU Study for Oncology Product Launch & Market Landscape in GCC
THE CHALLENGE The client required insights into HR-positive, HER2-negative breast cancer treatments to strategically position their product within existing treatment algorithms. This required a thorough assessment of factors such as market opportunities and target patient population. It also involved analyzing current testing practices, treatment paradigms and unmet needs.
HEALTHARK’S ROLE ATU (Awareness, Trial & Usage) Study & Strategic Insights Development Healthark collaborated with the client to conduct comprehensive market research & provide actionable insights that would directly inform their strategic decisions. The research was carried out through a structured, multi- phase approach: Hypothesis development & research plan Conduct primary research for market insights Insights synthesis & KPI development
THE IMPACT Healthark Insights assisted the client in developing brand-specific KPIs, enabling them to track product performance post-launch and make data-driven adjustments for ongoing optimization and success.